Htg Molecular Diagnostics Inc's ability to collect accounts receivable sequentially worsen to 5.21, pointing to a challenging and on top of that deteriorating business climate for the Laboratory Analytical Instruments industry. Htg Molecular Diagnostics Inc's Accounts Receivable average collection period in the Mar 31 2023 quarter, has increased to 70 days, from 63 days, in the Dec 31 2022 quarter.

If we take a look into Healthcare sector 415 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2023 from 2808 to 2853.

What is Receivable Turnover Ratio?
What is Htg Molecular Diagnostics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HTGM Receivables Turnover Ratio	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter
Y / Y Receivable Change	51.09 %	-32.06 %	-49.57 %	-11.44 %	-40.06 %
Y / Y Revenue Change	-12.83 %	-15.22 %	-50.37 %	-28.09 %	-17.47 %
Receivable Turnover Ratio (TTM)	5.21	5.8	5.38	5.38	5.61
HTGM's Total Ranking	# 2853	# 2808	# 2543	# 2772	# 2772
Accounts Receivable average collection period days	70	63	68	68	65
Seq. Receivable Change	-20.38 %	48.03 %	-23.72 %	68.05 %	-64.19 %
Seq. Revenue Change	-57.67 %	95.01 %	-16.14 %	25.93 %	-58.83 %

Receivable Turnover Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 21
Healthcare Sector	# 416
Overall Market	# 2853

Receivable Turnover Ratio Statistics
High	Average	Low
6.61	5.43	4.44
(Dec 31 2020)		(Mar 31 2017)

HTGM Company Profile • Back to HTGM Efficiency Comparisons • Compare HTGM Receivables Turnover Ratio to its Competitors

Financial Statements
Htg Molecular Diagnostics Inc's Accounts Receivable	$ 1 Millions	Visit HTGM's Balance sheet
Htg Molecular Diagnostics Inc's Sales TTM	$ 6 Millions	Visit HTGM's Income Statement
Sources of HTGM's Revenues		Visit HTGM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
HTGM's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
HTGM's Growth Rates	HTGM's Roa	HTGM's Inventory Turnover Ratio	HTGM's Dividend Comparisons
HTGM's Profitability Ratios	HTGM's Roi	HTGM's Asset Turnover Ratio	HTGM's Dividend Growth
HTGM's Valuation Ratios	HTGM's Roe	HTGM's Financial Strength Ratios	HTGM's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2023	Receivable at quarter ending Mar 31 2023
Arrowhead Pharmaceuticals Inc	15.05	$ 272.800 Millions	$ 18.123 Millions
Patterson Companies Inc	15.01	$ 6,471.471 Millions	$ 431.274 Millions
Rvl Pharmaceuticals Plc	14.81	$ 37.109 Millions	$ 2.506 Millions
Zomedica Corp	14.79	$ 20.661 Millions	$ 1.397 Millions
Editas Medicine Inc	14.66	$ 22.792 Millions	$ 1.555 Millions
Wearable Health Solutions, Inc.	14.38	$ 0.834 Millions	$ 0.058 Millions
Revance Therapeutics Inc	14.23	$ 156.635 Millions	$ 11.009 Millions
23andme Holding Co	14.18	$ 299.489 Millions	$ 21.127 Millions
Eton Pharmaceuticals Inc	13.82	$ 24.379 Millions	$ 1.765 Millions
Vystar Corporation	13.79	$ 5.297 Millions	$ 0.384 Millions
Intellia Therapeutics Inc	13.75	$ 53.475 Millions	$ 3.888 Millions
Corcept Therapeutics Inc	13.66	$ 413.824 Millions	$ 30.298 Millions
Strata Critical Medical Inc	13.65	$ 164.761 Millions	$ 12.071 Millions
Lifeloc Technologies Inc	13.23	$ 8.486 Millions	$ 0.641 Millions
Invo Fertility Inc	13.23	$ 1.008 Millions	$ 0.076 Millions
Cano Health Inc	13.20	$ 2,901.488 Millions	$ 219.766 Millions
International Stem Cell Corporation	13.06	$ 8.246 Millions	$ 0.631 Millions
Travere Therapeutics Inc	13.06	$ 220.524 Millions	$ 16.886 Millions
Skinvisible Inc	12.95	$ 0.224 Millions	$ 0.017 Millions
Talkspace Inc	12.94	$ 122.753 Millions	$ 9.489 Millions
Scienture Holdings Inc	12.44	$ 10.363 Millions	$ 0.833 Millions
Neurometrix Inc	12.42	$ 7.678 Millions	$ 0.618 Millions
Cue Health Inc	12.25	$ 328.831 Millions	$ 26.834 Millions
Exact Sciences Corporation	12.21	$ 2,188.345 Millions	$ 179.291 Millions
Avita Medical Inc	11.93	$ 37.432 Millions	$ 3.137 Millions
Agenus Inc	11.88	$ 94.985 Millions	$ 7.994 Millions
Teladoc Health Inc	11.85	$ 2,470.734 Millions	$ 208.418 Millions
Agios Pharmaceuticals Inc	11.74	$ 19.017 Millions	$ 1.620 Millions
Avalo Therapeutics Inc	11.69	$ 17.353 Millions	$ 1.485 Millions
Icu Medical Inc	11.67	$ 2,305.524 Millions	$ 197.537 Millions

Date modified: 2026-08-29T17:30:20+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.